Skip to main content
logo
Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
23.00
0.00 (0.00%)
At close: Dec 31, 2025, 4:00 PM EST
22.99
-0.01 (-0.04%)
Pre-market: Jan 2, 2026, 4:50 AM EST

Ultragenyx Pharmaceutical Revenue

Ultragenyx Pharmaceutical had revenue of $159.93M in the quarter ending September 30, 2025, with 14.65% growth. This brings the company's revenue in the last twelve months to $630.60M, up 20.63% year-over-year. In the year 2024, Ultragenyx Pharmaceutical had annual revenue of $560.23M with 29.01% growth.

Revenue (ttm)
$630.60M
Revenue Growth
+20.63%
P/S Ratio
3.56
Revenue / Employee
$487,325
Employees
1,294
Market Cap
2.22B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024560.23M125.98M29.01%
Dec 31, 2023434.25M70.92M19.52%
Dec 31, 2022363.33M11.92M3.39%
Dec 31, 2021351.41M80.38M29.66%
Dec 31, 2020271.03M167.32M161.32%
Dec 31, 2019103.71M52.22M101.41%
Dec 31, 201851.50M48.88M1,871.48%
Dec 31, 20172.61M2.48M1,863.91%
Dec 31, 2016133.00K--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings

RARE News

More News